In addition, ChREBP knocked-out mice have worse sensitivity to insulin, so ChREBP is able to dissociate conditions such as hepatic steatosis from insulin resistance and therefore contributes to the maintenance of insulin sensitivity with the counterpart of inducing a fatty liver [135]. Here, MLXIPL is linked to Hepatic steatosis.